{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# \n",
    "\n",
    "# ADHD Diagnostic Studies: Categorized by Measurement Type\n",
    "\n",
    "## Clinical Rating Scales and Diagnostic Interviews\n",
    "\n",
    "1.  Bakare & Jordanova (2020) - Brief screening measure development\n",
    "2.  Bastiaens & Galus (2018) - ASRS screener comparison DSM-IV vs DSM-5\n",
    "3.  Chen et al. (2021) - Machine learning ADHD classification\n",
    "4.  Chiasson et al. (2012) - ASRS in ADHD + substance abuse populations\n",
    "5.  Dakwar et al. (2012) - ADHD screening in substance use disorders\n",
    "6.  Dunlop et al. (2018) - ASRS in major depressive disorder\n",
    "7.  Eich et al. (2012) - New rating scale based on SCL-90-R\n",
    "8.  Erhardt et al. (1999) - Self-ratings reliability and validity\n",
    "9.  Faraone et al. (2000) - Symptom assessment children vs adults\n",
    "10. Gift et al. (2021) - Wender Utah Rating Scale psychometrics\n",
    "11. Grogan et al (2017) - CAARS, STAI (adhd and anxiety)\n",
    "12. Harrison et al (2016) - CAARS\n",
    "13. Houston et al. (2011) - Primary care screening instrument\n",
    "14. Kessler et al. (2010) - Adult ADHD Clinical Diagnostic Scale\n",
    "15. Kingston et al (2013) - Multiple measures + CPT\n",
    "16. Kwan et al (2024) - CAARS\n",
    "17. Lancaster et al (2018) - PAI\n",
    "18. Kumar et al. (2011) - MINI, CAARS, Screening in psychiatric inpatients\n",
    "19. Lewandowski et al. (2008) - College student symptom reporting\n",
    "20. Liu et al. (2023) - Machine learning screening approach\n",
    "21. Luderer et al. (2019) - ADHD screening in alcohol dependent patients\n",
    "22. Luty et al. (2009) - Self-report validation in substance users\n",
    "23. Marchant et al. (2015) - Self-Report Wender-Reimherr Scale\n",
    "24. Mattos et al. (2018) - DSM criteria in medical students\n",
    "25. McCann & Roy-Byrne (2004) - Self-report scales utility\n",
    "26. Mehringer et al. (2002) - Assessment of Hyperactivity and Attention tool\n",
    "27. Notzon et al. (2020) - CAADID, ADHD in cannabis use disorders\n",
    "28. Palma-Álvarez et al. (2023) - MINI-Plus ADHD module validation\n",
    "29. Palmer et al. (2023) - Screening in young autistic adults\n",
    "30. Reimherr et al. (2021) - Wender Utah Rating Scale versions\n",
    "31. Reyes et al. (2019) - ASRS utility in alcoholics\n",
    "32. Singh et al. (2015) - IPDE screening questionnaire\n",
    "33. Ustun et al. (2017) - WHO Adult ADHD Self-Report Scale\n",
    "34. van de Glind et al. (2013) - ASRS in substance use disorders\n",
    "35. Van Voorhees et al. (2011) - Self and other-ratings reliability\n",
    "36. Vitola et al. (2017) - DSM-5 criteria exploration\n",
    "37. Vizgaitis et al. (2023) - Self-reported symptoms analysis\n",
    "38. Young et al. (2016) - BAARS-IV, Prison inmate screening tool\n",
    "39. Young et al. (2005) - YAQ-S and YAQ-I symptomatology\n",
    "40. Young et al. (2023) - ASSET-BS screening measure development\n",
    "\n",
    "## Neuropsychological and Cognitive Tests\n",
    "\n",
    "1.  Adamou et al (2022) - Qb Test\n",
    "2.  Brunkhorst-Kanaan (2020) - QB Test\n",
    "3.  Cohen & Shapiro (2007) - Flicker task and CPT comparison\n",
    "4.  Edebol et al (2012) - QB Test, ADHD, Bipolar, Borderline PD\n",
    "5.  Edebol et al (2013) - QB Test\n",
    "6.  Elbaum et al. (2020) - MOXO-dCPT with eye tracking\n",
    "7.  Emser et al. (2018) - TAP, QB Test (child and adult), CAARS, Conners-3 (child) **(exclude?)**\n",
    "8.  Kovner et al. (1998) - Neuropsychological testing pilot study; multiple tests\n",
    "9.  Lee Booksh et al. (2010) - Attention measures in college students; multiple tests\n",
    "10. Lev et al. (2022) - MOXO-dCPT with eye tracking\n",
    "11. Lovejoy et al. (1999) - Executive function measures (multiple)\n",
    "12. Mostert et al. (2015) - DIVA + multiple neuropsychological tests\n",
    "13. Nielsen & Wiig (2011) - A Quick Test of Cognitive Speed (AQT)\n",
    "14. Paucke et al. (2021) - Go/NoGo + WURS + CAARS\n",
    "15. Pettersson et al. (2018) - DIVA 2.0 + ASRS vs 8 Neuropsychological tests\n",
    "16. Schreiber et al. (1999) - Rey-Osterrieth Complex Figure validation\n",
    "17. Shepler & Callan (2024) - Executive functioning differences\n",
    "18. Söderström et al. (2014) - QB Test + ASRS\n",
    "19. Solanto et al. (2004) - (WURS, CAARS, Brown ADD for dx) Conners CPT\n",
    "20. Spenceley et al. (2022) - Woodcock-Johnson IV detection\n",
    "21. Unal et al. (2019) - Stroop test, Stroop Plus, and Perceptual Selectivity test\n",
    "22. Wiig & Nielsen (2012) - A Quick Test of Cognitive Speed (AQT)\n",
    "23. Woods et al. (2002) - Multiple neuropsych tests\n",
    "\n",
    "## Neuroimaging Studies\n",
    "\n",
    "1.  Amen et al. (2021) - SPECT functional neuroimaging\n",
    "2.  Alves et al. (2024) - fMRI functional connectivity analysis, ADHD, ASD\n",
    "3.  Chaim-Avancini et al. (2017) - MRI pattern recognition\n",
    "4.  Schneider et al. (2014) - SPECT imaging comparison\n",
    "5.  Wang et al. (2013) - Regional homogeneity patterns resting-state fMRI\n",
    "6.  Wang et al. (2023) - Deep learning classification fMRI\n",
    "7.  Wolfers et al. (2016) - Brain activity pattern quantification, UN AFF, ADHD, Controls\n",
    "8.  Yao et al. (2018) - Machine learning feature selection rs-fMRI\n",
    "\n",
    "## EEG/Electrophysiological Studies\n",
    "\n",
    "1.  Biederman et al (2017) - Brain Network Activation (BNA), a novel ERP-based brain network analysis\n",
    "2.  Hadas et al. (2021) - TMS-EEG prefrontal activation\n",
    "3.  Kaur et al. (2020) - EEG phase space reconstruction\n",
    "4.  Kiiski et al. (2020) - Functional EEG connectivity\n",
    "5.  Kim et al. (2021) - Machine learning mismatch negativity\n",
    "6.  Mueller et al. (2011) - ERP components discrimination\n",
    "7.  Müller et al. (2020) - EEG/ERP biomarkers\n",
    "8.  Poil et al. (2014) - Age-dependent EEG changes (**children included?**)\n",
    "9.  Ponomarev et al. (2014) - Group ICA and current source density\n",
    "10. Shahaf et al. (2012) - Network oriented ERP analysis\n",
    "\n",
    "## Performance Validity/Effort Testing/Symptom Exaggeration\n",
    "\n",
    "### Performance-based ‘embedded’ validity indicators\n",
    "\n",
    "1.  Becke et al (2023) - Comprehensive Neuropsychological Test Battery + WURS\n",
    "2.  Berger et al (2021) - MOXO-d-CPT\n",
    "3.  Finley et al. (2023) - Embedded performance validity indicators\n",
    "4.  Khan et al. (2022) - Stroop test embedded indicators\n",
    "5.  Robinson et al. (2023) - CPT-3 validity indicators\n",
    "6.  Harrison and Armstrong (2020) - TOVA\n",
    "7.  Rogers et al. (2021) - WAIS-IV detection strategies\n",
    "8.  Phillips et al. (2023) - RAVLT + BVMT-R\n",
    "\n",
    "### Performance-based ‘standalone’ validity indicators\n",
    "\n",
    "1.  Morey (2019) - Tests of Attentional Distraction (TOAD)\n",
    "2.  Williamson et al. (2014) - TOMM, LMT, NV-MSVT, DMT\n",
    "3.  Abramson et al (2023) - Dot Counting Test (DCT)\n",
    "4.  Fuermaier et al (2016) - Embedded Figures Test\n",
    "\n",
    "### Symptom exaggeration rating scales\n",
    "\n",
    "1.  Aita et al. (2018) - Personality Assessment Inventory feigning\n",
    "2.  Cook et al. (2016) - Conners’ Infrequency Index validation\n",
    "3.  Courrégé et al. (2019) - ADHD Symptom Infrequency Scale\n",
    "4.  Finley et al (2024) - Clinical Assessment of Attention Deficit–Adult\n",
    "5.  Harrison & Armstrong (2016) - Exaggeration Index (EI)\n",
    "6.  Harrison et al. (2022) - PAI validity measures\n",
    "7.  Musso et al. (2016) - PAI utility\n",
    "8.  Potts et al. (2022) - Multidimensional ADHD Rating Scale\n",
    "9.  Ramachandran et al. (2019) - Subtle ADHD Malingering Screener\n",
    "10. Smith et al. (2017) - PAI feigning detection\n",
    "11. Young & Gross (2011) - MMPI-2\n",
    "\n",
    "### Combined neurocog test + rating scale\n",
    "\n",
    "1.  Sollman et al. (2010) - CAARS + TOMM, LMT, NVMST\n",
    "2.  Quinn (2003) - ADHD Behav Checklist + IVA CPT\n",
    "3.  Marshall et al. (2010) - WMT, CAT-A, b Test, DCT, etc\n",
    "4.  Harrison et al (2007) - CAARS, Woodcock Johnson Psychoeducational Battery-III\n",
    "\n",
    "## Biomarkers\n",
    "\n",
    "1.  Andrikopoulos et al. (2024) - Machine learning with physiological data\n",
    "2.  Grünblatt et al. (2012) - Transcription markers in whole blood\n",
    "3.  Jiminez et al (2021) - Eye vergence/oculomotor\n",
    "4.  Juselius Baghdassarian et al. (2018) - Auditory brainstem response (ABR)\n",
    "5.  Selek et al. (2012) - Total Antioxidative Status (TAS), Total Oxidative Status (TOS), and Oxidative Stress Index (OSI)\n",
    "6.  Udal et al. (2024) - Neuromuscular assessment\n",
    "7.  Woodruff et al. (2011) - A new blood test that measures blood cell membrane potential (expressed as membrane potential ratio \\[MPRTM\\])\n",
    "\n",
    "## Unclassified/Problematic Studies\n",
    "\n",
    "1.  Groom et al (2016) - CAARS + Autism scale + QB Test\n",
    "2.  Matte et al (2015) - Checking DSM-5 criteria for adults (e.g., lowering threshold)\n",
    "3.  Gillen (2003) - Dissertation"
   ],
   "id": "172ad9bb-8be1-4b58-8e45-3d02e9e222e4"
  }
 ],
 "nbformat": 4,
 "nbformat_minor": 5,
 "metadata": {}
}
